Integrated Graphene, the Scottish technology integration company which has pioneered a high performing, low cost, 3D Graphene Foam electrode, Gii-Sens®, for biosensing, has partnered with a world-leading team of scientists to develop a point-of-care biomedical test to revolutionise the safety of liver transplants.
Recent Posts
Today, we're delighted to introduce Michael Buhagiar, our Process Development Engineer. Michael supports the Gii-Cap development scientist team and is responsible for scaling up Gii-Cap+ electrodeposition processes.
Today, we're delighted to introduce Greig McLay, our Development Engineer. Grieg works in our Product Integration and System Engineering team and takes responsibility for the management and development of multiple bespoke medical diagnostics projects for external customers.
The cost of diagnostics technologies is one of the fundamental global health aspects to be considered for accessing the market with competitive and sustainable products. Exploiting the catalytic properties of the highly electroactive 3D Graphene Foam presents a number of advantages, such as a lower production cost and engineering, ease of mass production, and higher stability both in working conditions and long-term storage. To get a greater insight into significant opportunities afforded by electrochemical assay development services, today, we speak with Pablo, our Head of Research and Development, and Leila Kashefi, our Senior Electroanalytical Development Scientist to find out more about our Assay Development Services.
Over the last few decades, there had been increasing interest in both microfluidics and wearables, especially for remote, continuous monitoring and management of health and fitness. The rapid emergence of the wearables market has been influenced by big tech companies producing the likes of the Apple Watch, Fitbit and other wearable devices. The integration of microfluidic technology with multiplex capabilities into wearable devices is one of the most highly anticipated next-generation technologies. It has particular relevance in the fields of healthcare diagnostics, point-of-care (POC) testing and fitness monitoring with great potential to be applied to many more applications and market opportunities including the military.
Today, we're delighted to introduce Leila Kashefi, our Senior Electroanalytical Development Scientist. Leila conducts biosensor and assay development research on both internal and external projects as well as project management and supervision of a multidisciplinary team.
Diabetes is a chronic condition where the patient is unable to regulate their own blood glucose levels (1). Insulin is a peptide hormone produced by pancreatic islets beta cells: it breaks down glucose into glycogen that is absorbed by cells in the liver, fat and muscles. If blood glucose levels are not managed properly, it can result in patients developing life-threatening complications like diabetic ketoacidosis (DKA), heart attack or stroke.
In 2021, it was estimated around 537 million adults between the ages of 20-79 years old were living with diabetes: this is expected to rise to 643 million by 2030. 1 in 2 adults (240 million) with diabetes went undiagnosed and 541 million adults had an increased risk of developing type 2 diabetes (2).
Researchers at the University of Bath working in collaboration with industrial partner, Integrated Graphene, have developed a new sensing technique based on graphene foam for the detection of glucose levels in the blood. Since it is a chemical sensor instead of being enzyme-based, the new technology is robust, has a long shelf-life and can be tuned to detect lower glucose concentrations than current systems.
Today, we're delighted to introduce Beck Hunter, one of our Development Engineers. Beck works on the research and development of both internal and external projects to help bring new and innovative microfluidic products to life.
At Integrated Graphene, we have invented and patented a revolutionary design for manufacture process to produce high-performing and commercially viable pure 3D Graphene Foam directly onto desired substrate, in seconds. This means we can have an open production method to customise Gii-Sens® for specific designs and demand.